Jim Cramer Talks JPMorgan And Citigroup Earnings, Johnson & Johnson's Pause

Jim Cramer shared his thoughts on several big stocks Tuesday on CNBC's “Squawk Box.”

Cramer on Bank Earnings: When asked about JPMorgan Chase's JPM third-quarter earnings, Cramer said the company looked very good.

“I think people aren’t borrowing that much,” Cramer said, noting there can’t be a lot of defaults without a lot of borrowing.

Cramer said he would own JPMorgan over Citigroup Inc C. Cramer noted there will be more chatter about risk management with Citigroup and not with JPMorgan.

See Also: Jim Cramer Talks Monday's Rally, Apple's Move And More

Cramer on Johnson & Johnson: Cramer remained bullish on Johnson & Johnson JNJ, despite a pause on the company’s COVID-19 vaccine trial.

“It’s a pause, not a hold," said Cramer. He expects to get results from the pause over the next four to five days.

Cramer mentioned strong organic growth and good growth for the company’s medical devices.

He called Johnson & Johnson a “good stock right now" and think investors will regret selling the stock.